3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 1/2
2
Phase 1
2
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neoplasm Metastasis
2
Uveal Melanoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Differentiated Thyroid Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Control Groups
1
Acceptance and Commitment Therapy
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neurofibroma, Plexiform
×
AZD 6244
×
Clear all
NCT04924608
2026-03-23
KOMET
AstraZeneca
Phase 3
Active not recruiting
145 enrolled
17 charts
1 FDA